Abalos Therapeutics

Product / Service Summary

Task: To fight cancer through the body's own immune system. The goal of Abalos' arena virus-based product candidate is to activate the body's innate and adaptive immune response by multiplying the viruses in cancer cells.


Life Science & Healthcare

Seed Stage

Manufacturing

B2B

Description

Abalos Therapeutics uses the unique immune stimulation of arena viruses to develop a new approach to fight cancer. This will enable the full power of the entire immune system to be used specifically against cancer cells. Under the leadership of experienced biotech entrepreneurs and immunology pioneers, Abalos strives for a quantum leap in immunoncology.


Abalos Therapeutics Funding


Abalos Therapeutics Team Members


Recent news about Abalos Therapeutics

15.10.2019

Life Sciences-Start-up Abalos Therapeutics sichert sich 12 Mio. EUR

Abalos Therapeutics will Arenaviren für den Kampf gegen Krebs nutzen. Das Life Sciences-Start-up sichert sich in der Series A 12 Mio. EUR.

VC-Magazin VC-Magazin Read full article




Startbase Data

Added: 16.10.2019
Updated: 16.09.2020
  • Validated team members on Startbase
  • Registered at a German Handelsregister
  • Headquarter located in Germany
  • Scalable Business Model
  • Innovative Business Model

Abalos Therapeutics

Research, development and commercialization of innovative drugs and therapies primarily based on viruses for the treatment of cancer.
  • 2019
  • 1-10 Employees
  • Abalos Therapeutics GmbH
  • Essen, DE